instruction stringlengths 1.03k 1.87k | output stringlengths 554 1.04k |
|---|---|
SUBJECT: Adverse event report Product A plus Product B completed treatment historically
Dear Drug Safety Department,
I am the Consultant Dermatologist at a dialysis centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient expe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Urgent adverse event Product A and Product B discontinued prior to event
Dear Adverse Events Reporting Centre,
I am the Ward Nurse Manager at a dialysis centre network and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient expe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Product A adverse reaction with Product B historical exposure documented
Dear Corporate Drug Safety Department,
I am the Consultant Rheumatologist at a private oncology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A suspected adverse reaction with Product B unchanged during reaction
Dear Regional Pharmacovigilance Lead,
I am the Consultant Nephrologist at a gastroenterology clinic partnership and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse even... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Urgent adverse event Product A and Ibuprofen continued without change
Good morning,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 73 year old male patient started on Product A 6 weeks ago ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A reaction and suspected combined effect Product A and Omeprazole formal notification
Dear Pharmacovigilance Team,
I am the Medical Director at a cancer centre network and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse even... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Dear Regional Pharmacovigilance Lead,
I am the Senior Consultant at a regional hospital trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A reaction report with concomitant Atorvastatin therapy
Dear Corporate Drug Safety Department,
I am the Consultant Rheumatologist at a large endocrinology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Suspected adverse event with Product A and Product A and Metformin jointly suspected
Dear Pharmacovigilance Team,
I am writing as the caregiver for my elderly aunt Catherine Rodriguez to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event wh... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A adverse event and Metformin maintained as background medication report
Dear Pharmacovigilance and Risk Management Team,
I am the Pharmacy Operations Manager at an integrated care system and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wis... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Good morning,
I am the Director of Clinical Services at a private oncology clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event wher... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Suspected adverse event with Product A and dual drug reaction Product A and Atorvastatin
Good morning,
I am the Consultant Rheumatologist at a clinical research site network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where t... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A suspected adverse reaction with suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am writing as the caregiver for my sister Stephanie Meyer to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the tr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Formal adverse event notification Product A with Omeprazole maintained as background medication
Dear Drug Safety Department,
I am the Consultant Rheumatologist at a home healthcare nursing agency and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A adverse event and past Product B exposure report
Dear Sir or Madam,
I am the Director of Clinical Services at a specialist dermatology centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a 37... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Clinical Safety and Regulatory Affairs,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Urgent adverse event Product A and Product A and Amlodipine jointly suspected
Dear Patient Safety Team,
I am the Consultant Nephrologist at a pain management clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Urgent adverse event Product A and suspect Product B also implicated
Dear Patient Safety Team,
I am the Clinical Pharmacy Director at a university hospital department and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a serious adverse... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A suspected adverse reaction with ongoing Ibuprofen use alongside Product A
Good morning,
I am the Senior Consultant at a chain of retail pharmacies and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 53 y... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Serious adverse event report Product A and Product B completed course before reaction
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my mother Benjamin Wood to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Formal adverse event notification Product A with suspect Product A with suspect Metformin
Dear Clinical Safety and Regulatory Affairs,
I am the Ward Nurse Manager at a cancer centre network and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious ad... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Dear Pharmacovigilance and Risk Management Team,
I am the Senior Nurse Practitioner at a corporate occupational health provider and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a ser... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Safety report Product A and suspect Product B also implicated
To Whom It May Concern,
I am the Ward Nurse Manager at a pharmaceutical benefit manager and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse event where the treating physician... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Dear Drug Safety Department,
I am the Medical Director at a private cardiology practice group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
Dear Post-Marketing Surveillance Unit,
I am the Director of Clinical Services at a childrens hospital outpatient department and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Serious adverse event report Product A and ongoing Product B treatment
Dear Drug Safety Department,
I am the Head of Pharmacy Services at a clinical research site network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Adverse reaction report involving Product A and Product B ongoing without change
Dear Pharmacovigilance Team,
I am the Pharmacy Operations Manager at a multi-site primary care network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Suspected adverse event with Product A and Metformin stable during Product A reaction
Hi,
I am the Ward Nurse Manager at a mental health trust and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a 59 year old mal... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Formal adverse event notification Product A with Lisinopril also suspected by physician
Dear Sir or Madam,
I am the Senior Nurse Practitioner at a community health partnership covering 12 clinics and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a seri... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Serious adverse event report Product A and Product B prior use not relevant
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Dermatologist at a womens health clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse eve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Urgent adverse event Product A and suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am the Consultant Pulmonologist at a residential care home network managing over 400 elderly residents across 5 facilities and I am writing to formally report an adverse event involving a patient under ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Suspected adverse event with Product A and suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physici... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A suspected reaction with physician suspects both Product A and Ibuprofen – formal report
Dear Sir or Madam,
I am the Clinical Pharmacist at a pathology and diagnostics consortium and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to rep... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Dear Clinical Safety and Regulatory Affairs,
I am the Medical Director at a cancer centre network and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Safety report Product A and suspected Lisinopril co-reaction
Dear Adverse Events Reporting Centre,
I am the Consultant Pulmonologist at a home healthcare nursing agency and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the tr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Product A adverse event and Product B prior use not relevant report
Dear Corporate Drug Safety Department,
I am the Consultant Dermatologist at a specialist dermatology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A adverse event and suspect Product A with suspect Lisinopril report
To Whom It May Concern,
I am the Consultant Dermatologist at a university hospital department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A adverse event and Product B completed treatment historically report
Dear Patient Safety Team,
I am the Consultant Hepatologist at a corporate occupational health provider and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pa... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Safety report Product A and suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as cont... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Safety report Product A and Product B as background therapy
Hi,
I am the Consultant Pulmonologist at a specialist neurology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 42 year old male patient on Pr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
Dear Pharmacovigilance Team,
I am the Clinical Pharmacist at a group of private outpatient clinics and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a serious adver... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A adverse event and Product B discontinued prior to event report
Good morning,
I am the Consultant Cardiologist at a university hospital department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 29 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A suspected adverse reaction with ongoing Product B treatment
Dear Global Safety Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 53 year old female patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Urgent adverse event Product A and Product B maintained during event
Dear Pharmacovigilance Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 73 year old male patient started on Product ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Dear Global Safety Unit,
I am the Consultant Pulmonologist at a mental health trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Adverse event report Product A plus past Product B exposure
Dear Regional Pharmacovigilance Lead,
I am the Consultant Gastroenterologist at a faith-based hospital system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Dear Corporate Drug Safety Department,
I am the Ward Nurse Manager at a womens health clinic group and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Suspected adverse event with Product A and Product B maintained during event
Dear Clinical Safety and Regulatory Affairs,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Adverse event report Product A plus Product B discontinued prior to event
Dear Medical Affairs and Drug Safety,
I am the Consultant Endocrinologist at a geriatric medicine consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Serious adverse event report Product A and previous Product B therapy
Dear Drug Safety Department,
I am the Consultant Hepatologist at a wound care centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Adverse reaction report involving Product A and both Product A and Omeprazole identified as suspect
To Whom It May Concern,
I am the Director of Clinical Services at a managed care organisation and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a se... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Adverse reaction report involving Product A and Product A and Amoxicillin both implicated
Dear Patient Safety Team,
I am the Head of Pharmacy Services at a wound care centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Formal adverse event notification Product A with Metformin excluded as causative agent
Dear Patient Safety Team,
I am the Senior Consultant at a residential care home network managing over 400 elderly residents across 5 facilities and I am writing to formally report an adverse event involving a patient under m... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse event report Product A plus previous Product B therapy
Dear Global Safety Unit,
I am the Consultant Hepatologist at an integrated care system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 60 year old... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Urgent adverse event Product A and Metformin stable during Product A reaction
Dear Regional Pharmacovigilance Lead,
I am the Chief of Medicine at a tertiary referral hospital and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Pharmacovigilance report Product A with suspected Amlodipine co-reaction
Dear Post-Marketing Surveillance Unit,
I am the Pharmacy Operations Manager at a womens health clinic group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a s... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A suspected reaction with Product B completed treatment historically – formal report
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 29 year old... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Adverse event notification for Product A with Product B stable throughout event
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Gastroenterologist at a faith-based hospital system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adver... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am writing as the caregiver for my husband Justin Kelley to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating phys... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Dear Global Safety Unit,
I am the Pharmacy Operations Manager at a wound care centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a serious... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A adverse reaction with dual suspect Product A and Omeprazole
Dear Pharmacovigilance Team,
I am writing as the caregiver for my wife Dorothy Henry to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physician su... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A suspected adverse reaction with Product B no longer taken
Hi,
I am the Consultant Neurologist at a specialist dermatology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 48 year old female pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A suspected reaction with Amoxicillin unchanged during event onset – formal report
Dear Drug Safety Department,
I am the Consultant Neurologist at a specialist dermatology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Adverse event notification for Product A with Product B discontinued prior to event
Hi,
I am the Attending Physician at a rehabilitation and long-term care facility and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient exp... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am the Senior Consultant at a geriatric medicine consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event w... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A adverse event and Product A and Levothyroxine both implicated report
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Haematologist at a dialysis centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Patient Safety Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects both medica... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse event report Product A plus Product A and Levothyroxine both implicated
Dear Corporate Drug Safety Department,
I am the Consultant Haematologist at a tertiary referral hospital and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Product A reaction report with suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as c... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction and ongoing Lisinopril use alongside Product A formal notification
Dear Patient Safety Team,
I am the Consultant Cardiologist at a specialist neurology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
Dear Global Safety Unit,
I am the Senior Nurse Practitioner at a university hospital department and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse event where th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse reaction report involving Product A and Product B no current exposure
Hi,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 37 year old female patient initiated on... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
Dear Global Safety Unit,
I am the Senior Nurse Practitioner at a hepatology referral centre and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse event where the tr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A suspected reaction with Product B not currently administered – formal report
Dear Clinical Safety and Regulatory Affairs,
I am writing as the caregiver for my father Matthew Sanchez to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Dear Sir or Madam,
I am the Consultant Gastroenterologist at a faith-based hospital system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A suspected reaction with Product B past use excluded – formal report
Dear Global Safety Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 37 year old female... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Product A adverse event and Lisinopril maintained as background medication report
Dear Medical Affairs and Drug Safety,
I am the Ward Nurse Manager at a wound care centre network and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Urgent adverse event Product A and concomitant Product B therapy
Dear Corporate Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 38 year old male ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Sir or Madam,
I am the Consultant Rheumatologist at a Veterans Affairs medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating physi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Urgent adverse event Product A and suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am the Consultant Cardiologist at a rehabilitation and long-term care facility and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Good morning,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects both m... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A adverse event and Amoxicillin stable during Product A reaction report
Good morning,
I am the Head of Pharmacy Services at a dialysis centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A adverse reaction with ongoing Product B treatment
Dear Sir or Madam,
I am the Clinical Pharmacy Director at an integrated care system and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patient experience... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Suspected adverse event with Product A and past Product B exposure
Dear Global Safety Unit,
I am the Consultant Pulmonologist at a specialist neurology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 38... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A suspected reaction with suspect Product B also implicated – formal report
Dear Pharmacovigilance Team,
I am the Senior Consultant at a faith-based hospital system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse event report Product A plus concomitant Ibuprofen therapy
Dear Corporate Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 45 year old female patient initiated ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A reaction and both Product A and Ibuprofen identified as suspect formal notification
Dear Global Safety Unit,
I am writing as the caregiver for my wife Andrew Lane to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the tre... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A adverse reaction with Product B ongoing without change
Dear Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 38 year old male patient on... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Dear Global Safety Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician susp... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Safety report Product A and continued Product B administration
Hi,
I am the Clinical Pharmacy Director at a tertiary referral hospital and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patient experienced a 62 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Adverse event report Product A plus concomitant Amlodipine therapy
Dear Global Safety Unit,
I am writing as the caregiver for my wife Henry West to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 48 year old female pa... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Urgent adverse event Product A and Product B ongoing without change
Dear Medical Affairs and Drug Safety,
I am the Consultant Neurologist at a rehabilitation and long-term care facility and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. T... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Adverse event report Product A plus ongoing Omeprazole use alongside Product A
Good morning,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 64 year old male patient on ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A suspected reaction with suspect Product B also implicated – formal report
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects bo... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Suspected adverse event with Product A and Product B past use excluded
To Whom It May Concern,
I am the Clinical Nurse Specialist at a residential care home network managing over 400 elderly residents across 5 facilities and I am documenting this adverse event report on behalf of a patient under our ward care.... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Safety report Product A and Product B concomitant medication
Dear Clinical Safety and Regulatory Affairs,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 60 year old mal... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Pharmacovigilance and Risk Management Team,
I am the Senior Nurse Practitioner at a respiratory medicine centre and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a seriou... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Product A reaction and Product B no current exposure formal notification
Dear Pharmacovigilance and Risk Management Team,
I am the Director of Clinical Services at a faith-based hospital system and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Suspected adverse event with Product A and suspect Product B also implicated
Dear Pharmacovigilance Team,
I am the Pharmacy Operations Manager at a respiratory medicine centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a seriou... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
To Whom It May Concern,
I am the Attending Physician at a metropolitan ambulance service medical liaison office and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.